Methamphetamine Misuse Increases Risk of Adverse Heart Health Outcomes
August 29th 2022This new study investigated risk factors for cardiovascular disease, including heart failure, among hospitalized patients with a recent history of methamphetamine use and priority patient populations to target.
Read More
Review Examines Traditional, Newer Forms of CBT on Diabetes-Related Distress
August 29th 2022While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.
Read More
Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC
August 29th 2022Hatim Husain, MD, associate professor in the Department of Medicine at UC San Diego, discuses must-haves for successful biomarker testing in lung cancer—in particular, non–small cell lung cancer (NSCLC)—and how the field is adapting to the targeted treatment needs of its patients.
Watch
Lack of state funding and understaffing are threatening the vaccination campaign for novel Omicron-specific booster shots; experts explore the differences between subcutaneous and intradermal delivery of monkeypox vaccines; HHS’ Office for Civil Rights is struggling to manage rising cases of cyberattacks on US health care organizations.
Read More
Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy
August 28th 2022The real-world study adds to previous randomized controlled trial findings suggesting that shorter courses of antibiotic therapy can be sufficient for hospitalized patients with mild or moderate community-acquired pneumonia.
Read More
TKI Therapy for Chronic-Phase CML Leads to Comparable Outcomes for AYAs and Older Adults
August 28th 2022A retrospective study found that adolescents and young adults (AYA) receiving tyrosine kinase inhibitors (TKI) therapy for chronic-phase chronic myeloid leukemia (CML) had similar prognoses to older patients despite also showing higher tumor burden at diagnosis.
Read More
Deepwater Horizon Oil Spill Led to 60% Higher Risk of Later Asthma for Cleanup Workers
August 28th 2022Workers involved in cleaning up the 2010 Deepwater Horizon disaster, the country’s largest oil spill, were 60% more likely to be diagnosed with asthma or experience asthma symptoms 1 to 3 years afterwards, compared with those who were not involved in the cleanup.
Read More
More Diverse, Medically Complex Patients Hospitalized Less Often After Home-Based Cardiac Rehab
August 27th 2022While past studies have indicated that home-based and center-based cardiac rehabilitation results in similar outcomes for lower-risk patients, information about patients who are more medically complicated and racially and ethnically diverse is unknown.
Read More
DIY Automated Insulin Delivery Systems Bring Unique Challenges to HCPs
August 27th 2022Do-it-yourself (DIY) automated insulin delivery systems have gained rapid uptake, yielding self-reported improvements in glycemic control and quality of life for patients, but creating unique challenges for health care providers (HCPs).
Read More
Advocate Highlights Misconceptions in the Management of Hidradenitis Suppurativa
August 27th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected by hidradenitis suppurativa (HS), spoke on misconceptions she’s encountered on her HS disease journey and the importance for physicians to be conscientious of their advice to patients.
Watch
Wearable Device, Supervised Exercise Linked to Superior Weight Loss Outcomes
August 27th 2022Wearing a physical activity tracker and receiving personalized exercise feedback was linked to better results in exercise performance, weight loss, and other health outcomes among individuals with obesity.
Read More
Dr Viral Shah Emphasizes Importance of Patient Education on T1D Technologies
August 27th 2022The next step for health care professionals is to teach patients how to act on the data collected by intermittently scanned glucose sensing technologies, according to Viral Shah, MD, an endocrinologist and scientist.
Watch
FDA Approves Pemigatinib for Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
August 26th 2022The FDA Friday approved pemigatinib (Pemazyre), a selective fibroblast growth factor (FGFR) inhibitor, to treat adults who have relapsed or refractory (R/R) myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement, a very rare and aggressive cancer.
Read More
What We’re Reading: Moderna Sues Pfizer; Access to Research; Monkeypox Cases Drop
August 26th 2022Moderna is suing Pfizer-BioNTech for vaccine patent infringement; the White House is pushing for American citizens to have access to all publicly funded research by 2026; Monkeypox cases drop 21% globally, stopping a months-long increase.
Read More
Nusinersen Linked With Modest Improvements in Adult SMA
August 26th 2022The patients, from 5 referral centers, were followed for at least 6 months and showed modest improvements in both motor and functional scales when treated with the antisense oligonucleotide for spinal muscular atrophy (SMA).
Read More
Dr Jason Ezra Hawkes Discusses How AD Immunology Informs Screening Practices
August 26th 2022Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, explained the utility of type 2 inflammation pathways and the microbiome in understanding the immune dysregulation associated with atopic dermatitis (AD).
Watch
Combination Treatment Provides Short-term Endoscopic Relief in CRSwNP Subtype
August 25th 2022This study investigated combination treatment of antibiotics plus corticosteroids among persons with aspirin-exacerbated respiratory disease, a subtype of chronic rhinosinusitis with nasal polyposis (CRSwNP).
Read More